PharVision Advisers’s Ubiquiti UI Stock Holding History

PharVision Advisers’s Portfolio UI Stock Details UI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-745	Closed	-$412K	–	620
2025 Q4	$412K	Buy	+745	New	+$471K	0.21%	110

Other funds holding UI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

SIM

SW Investment Management Telluride, Colorado $451M AUM 79.06% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PharVision Advisers's UI Position: Q1 2026 in Review

PharVision Advisers sold out of Ubiquiti (UI) in Q1 2026, closing a stake of 745 shares — an estimated $412K sold.

PharVision Advisers first reported a position in UI in Q4 2025 and held it in 1 quarter. The position peaked at $412K in Q4 2025. 384 funds tracked by Wall St. Rank hold UI as of Q1 2026.

PharVision Advisers reported no remaining Ubiquiti position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 745 Ubiquiti shares in Q1 2026, an estimated $412K.
PharVision Advisers first reported a position in Ubiquiti in Q4 2025 and held it in 1 quarter.
PharVision Advisers's Ubiquiti position peaked at $412K in Q4 2025.
384 funds tracked by Wall St. Rank held Ubiquiti as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.